Join Chris Walsh, CEO at Acadia as he discusses how the OTC Derivatives industry is mainstreaming UMR compliance and starting to move towards optimizing their performance. Chris shares his insights on how the industry is adapting to a more holistic approach to risk, margin and collateral -coining the phrase Optimal Margin Management.
Recorded and produced by Lansons
Listen time – 13 minutes
This episode dives into the evolving regulatory and modelling landscape in the UK for traded risk. Scott Sobolewski speaks with Xabier Anduagaand Joey O’Brien...
In the first episode of Ahead of the Curve, AcadiaSoft’s Head of Community Development Mark Demo and Head of Industry & Regulatory Strategy John...
Scott O’Malia, CEO at ISDA returns for a ‘threepeat’, his 3rd time on the podcast. He joins John Pucciarelli, Head of Industry Engagement at...